Arthur S. Levine, MD
Arthur S. Levine, MD, is senior vice chancellor for the health sciences and John and Gertrude Petersen Dean of the University of Pittsburgh School of Medicine. Dr. Levine works closely with UPMC (University of Pittsburgh Medical Center), one of the largest academic medical centers in the nation, to ensure that health care delivery, biomedical research, and education—the three legs of the "classic academic stool"—remain equally strong and suited for future growth. Under his direction, the medical school entered into the top 10 list of recipients of National Institutes of Health (NIH) funding in 1998 and has since climbed within this enviable ranking. The faculty of the School of Medicine currently ranks fifth nationally in total NIH research funding received.
As leader of all six health sciences schools, Dr. Levine directs the University's efforts to invigorate and expand its health sciences research portfolio. In this role, he has focused on research that exploits the vast amount of data emerging from the human genome project and on the newly emerging and powerful technologies that enable us to visualize the three-dimensional structures, as well as the interactions, of molecules, cells, and other biological structures.
The University has launched a number of multidisciplinary research centers and institutes during Dr. Levine's tenure, including the Brain Institute, Drug Discovery Institute, Center for Vaccine Research, and Institute for Precision Medicine. In 2006, the University was one of 12 American institutions selected by NIH to receive the first Clinical and Translational Science Awards. This $83.5 million grant (renewed in 2011 for $67.3 million) established Pitt's Clinical and Translational Science Institute (CTSI), which works across the University and with UPMC to speed the translation of research advances into clinical practice. More recently, Pitt was awarded a prestigious $11 million grant to create a Center of Excellence for Big Data Computing. Eleven such grants were awarded from a pool of 136 applications to NIH's new Big Data to Knowledge initiative, known as BD2K.
Dr Levine received his MD from the Chicago Medical School, now the Rosalind Franklin University of Medicine and Science. He completed a residency in pediatrics at the University of Minnesota Hospitals, Minneapolis, and a fellowship in hematology and biochemical genetics at the University of Minnesota. Prior to his appointment at the University of Pittsburgh, Dr. Levine served at NIH for more than three decades, having joined the National Cancer Institute in 1967. From 1982 to 1998, he was scientific director of the National Institute of Child Health and Human Development, widely recognized as a global leader in developmental biology.